Basics Array Technologies, Inc. Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. IPO Date: October 15, 2020 Sector: Technology Industry: Solar Market Cap: $1.21B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 3.31% Avg Daily Range (30 D): $0.33 | 4.06% Avg Daily Range (90 D): $0.34 | 4.25% Institutional Daily Volume Avg Daily Volume: 4.44M Avg Daily Volume (30 D): 5.91M Avg Daily Volume (90 D): 6.56M Trade Size Avg Trade Size (Sh.): 123 Avg Trade Size (Sh.) (30 D): 134 Avg Trade Size (Sh.) (90 D): 148 Institutional Trades Total Inst.Trades: 6,038 Avg Inst. Trade: $2.29M Avg Inst. Trade (30 D): $2.52M Avg Inst. Trade (90 D): $2.53M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $5.04M Avg Closing Trade (30 D): $4.48M Avg Closing Trade (90 D): $4.78M Avg Closing Volume: 367.01K     News Sep 28, 2025 @ 11:30 AM Is Nextracker Stock a Buy Now? Source: Leo Sun Aug 21, 2025 @ 12:00 PM Shoals Technologies Group Appoints Aaron Zadeh as ... Source: Shoals Technologies Group Aug 14, 2025 @ 8:15 PM ARRAY Technologies Completes Acquisition of APA So... Source: Globe Newswire Jun 25, 2025 @ 1:50 AM Array Technologies Announces Pricing of Upsized Of... Source: Array Technologies, Inc. Jun 18, 2025 @ 12:16 PM Array Technologies Boosts Solar Play With $179 Mil... Source: Nabaparna Bhattacharya Financials   TTM Q2 2025 Q1 2025 Basic EPS $.12 $.19 $.02 Diluted EPS $.12 $.19 $.02 Revenue $ 393.49M $ 362.24M $ 302.36M Gross Profit $ 105.67M $ 97.12M $ 76.43M Net Income / Loss $ 33.5M $ 43.26M $ 16.75M Operating Income / Loss $ 45.45M $ 46.38M $ 27.28M Cost of Revenue $ 287.82M $ 265.12M $ 225.94M Net Cash Flow $ -155.67M $ 29.28M $ -14.65M PE Ratio 65.75